MLH1 and colonic neoplasm: MLH1 promoter methylation is the most commonly observed alteration causing MSI in sporadic colon tumors [23], and consequently the tumors with MLH1 promoter methylation are likely to represent most of the MSI tumors of the cohort, although we did not evaluate MSI independently.